rs2181440
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001421.4(ELF4):c.1509G>A(p.Thr503=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,207,984 control chromosomes in the GnomAD database, including 27,550 homozygotes. There are 100,244 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 2250 hom., 7342 hem., cov: 24)
Exomes 𝑓: 0.26 ( 25300 hom. 92902 hem. )
Consequence
ELF4
NM_001421.4 synonymous
NM_001421.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.45
Genes affected
ELF4 (HGNC:3319): (E74 like ETS transcription factor 4) The protein encoded by this gene is a transcriptional activator that binds and activates the promoters of the CSF2, IL3, IL8, and PRF1 genes. The encoded protein is involved in natural killer cell development and function, innate immunity, and induction of cell cycle arrest in naive CD8+ cells. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant X-130067204-C-T is Benign according to our data. Variant chrX-130067204-C-T is described in ClinVar as [Benign]. Clinvar id is 402824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-130067204-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.355 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELF4 | NM_001421.4 | c.1509G>A | p.Thr503= | synonymous_variant | 9/9 | ENST00000308167.10 | NP_001412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELF4 | ENST00000308167.10 | c.1509G>A | p.Thr503= | synonymous_variant | 9/9 | 1 | NM_001421.4 | ENSP00000311280 | P1 | |
ELF4 | ENST00000335997.11 | c.1509G>A | p.Thr503= | synonymous_variant | 9/9 | 1 | ENSP00000338608 | P1 |
Frequencies
GnomAD3 genomes AF: 0.215 AC: 24061AN: 111875Hom.: 2251 Cov.: 24 AF XY: 0.215 AC XY: 7339AN XY: 34069
GnomAD3 genomes
AF:
AC:
24061
AN:
111875
Hom.:
Cov.:
24
AF XY:
AC XY:
7339
AN XY:
34069
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.254 AC: 45328AN: 178787Hom.: 4260 AF XY: 0.249 AC XY: 16212AN XY: 65007
GnomAD3 exomes
AF:
AC:
45328
AN:
178787
Hom.:
AF XY:
AC XY:
16212
AN XY:
65007
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.257 AC: 281919AN: 1096059Hom.: 25300 Cov.: 34 AF XY: 0.257 AC XY: 92902AN XY: 361801
GnomAD4 exome
AF:
AC:
281919
AN:
1096059
Hom.:
Cov.:
34
AF XY:
AC XY:
92902
AN XY:
361801
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.215 AC: 24056AN: 111925Hom.: 2250 Cov.: 24 AF XY: 0.215 AC XY: 7342AN XY: 34129
GnomAD4 genome
AF:
AC:
24056
AN:
111925
Hom.:
Cov.:
24
AF XY:
AC XY:
7342
AN XY:
34129
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 41% of patients studied by a panel of primary immunodeficiencies. Number of patients: 39. Only high quality variants are reported. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at